Brevan Howard Capital Management’s Inspire Medical Systems INSP Stock Holding History

Brevan Howard Capital Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Buy	43,158 +37,701	+691%	+$1.79M	0.01%	731
2026 Q1	$281K	Sell	5,457 -5,328	-49%	-$373K	﹤0.01%	1666
2025 Q4	$995K	Sell	10,785 -2,442	-18%	-$234K	0.01%	771
2025 Q3	$981K	Sell	13,227 -8,324	-39%	-$843K	﹤0.01%	905
2025 Q2	$2.8M	Buy	21,551 +17,688	+458%	+$2.56M	0.02%	602
2025 Q1	$615K	Buy	+3,863	New	+$699K	0.01%	671
2023 Q3	–	Sell	-715	Closed	-$232K	–	412
2023 Q2	$232K	Buy	+715	New	+$204K	﹤0.01%	172

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Brevan Howard Capital Management's INSP Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Inspire Medical Systems (INSP) stake by 691% in Q2 2026, buying an estimated $1.79M and bringing the position to 43,158 shares worth $1.93M. The position accounts for 0.01% of the portfolio, ranked #731.

Brevan Howard Capital Management first reported a position in INSP in Q2 2023 and has held it in 7 quarters since. The position peaked at $2.8M in Q2 2025. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

Brevan Howard Capital Management held 43,158 shares of Inspire Medical Systems worth $1.93M as of Q2 2026.
Brevan Howard Capital Management bought 37,701 Inspire Medical Systems shares in Q2 2026, an estimated $1.79M.
Inspire Medical Systems made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #731 holding.
Brevan Howard Capital Management first reported a position in Inspire Medical Systems in Q2 2023 and has held it in 7 quarters since.
Brevan Howard Capital Management's Inspire Medical Systems position peaked at $2.8M in Q2 2025.
275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.